Skip to main content

Ed Ridley-Day

x
Ed Ridley-Day

Ed is a Partner of Redburn and a member of the Healthcare team. He specialises in Digital Health, Life Sciences Equipment, Endoscopy, Robotic Surgery and Radiology and has analysed the Medical Technology sector since XX. His recent research includes Diagnostics: Technology Shift (Oct 2021, 214 pages), which argued the c$77bn in-vitro diagnostic market is set to accelerate, supported by advances in personalised medicine, new technology and COVID-19-inspired improvements in molecular and point-of-care technology. Digital Health: Potential Realised (Jan 2021, 144 pages) examined how technology is transforming healthcare through early diagnosis, streamlined therapy and improved outcomes. Ed previously covered Medical Technology at Bank of America Merrill Lynch.

Contact Ed Ridley-Day | Back to Analysts